[GUEST ACCESS MODE: Data is scrambled or limited to provide examples. Make requests using your API key to unlock full data. Check https://lunarcrush.ai/auth for authentication information.]

@BiotechTV Avatar @BiotechTV BiotechTV

BiotechTV posts on X about $imrx, $aclx, mek, $4543t the most. They currently have XXXXX followers and XXX posts still getting attention that total XXX engagements in the last XX hours.

Engagements: XXX #

Engagements Line Chart

Mentions: XX #

Mentions Line Chart

Followers: XXXXX #

Followers Line Chart

CreatorRank: XXXXXXXXX #

CreatorRank Line Chart

Social Influence #

Social category influence stocks cryptocurrencies exchanges fashion brands finance

Social topic influence $imrx #4, $aclx, mek, $4543t, head of, applications, derek, $slno, $srpt, $lxeo

Top assets mentioned Arcellx, Inc. Common Stock (ACLX) Soleno Therapeutics, Inc. Common Stock (SLNO) Sarepta Therapeutics, Inc. (SRPT) Crinetics Pharmaceuticals, Inc. (CRNX) Xenon Pharmaceuticals Inc (XENE) Biohaven Pharmaceutical Holding Company Ltd. (BHVN) Vertex Protocol (VRTX) Dyne Therapeutics, Inc. Common Stock (DYN) IDEAYA Biosciences, Inc. Common Stock (IDYA) Sanofi (SNY)

Top Social Posts #

Top posts by engagements in the last XX hours

": @arcellx CEO Rami Elghandour discusses the results presented today of the iMMagine-1 Study for the company's BCMA CAR-T. #EHA2025 $ACLX Full video:"
X Link @BiotechTV 2025-06-14T19:48Z 9438 followers, 7284 engagements

": @Immuneering's CEO walks us through the company's MEK data in pancreatic cancer and explains the science behind 'deep cyclic inhibition'. $IMRX Full video:"
X Link @BiotechTV 2025-10-09T04:20Z 9437 followers, 3870 engagements

": Oxford's @organ_ox became one of the UK's biggest news stories when it was announced it would be acquired by Japan's Terumo for approximately $XXX billion - here's the revolutionary technology behind it. Full video:"
X Link @BiotechTV 2025-10-10T13:43Z 9437 followers, 1177 engagements

": @benchlings Head of Product - Applications Derek Halliday describes how technology is changing the Development side of R&D and how Benchling has helped Merck modernize its bioanalytical systems in this regard. #sponsored"
X Link @BiotechTV 2025-10-14T21:10Z 9437 followers, 1514 engagements

": R.W. Baird Managing Director & Senior Biotech Analyst @BrianSkorney discusses numerous battleground companies in biotech. $SLNO $SRPT $LXEO $ENTA $CRNX $VRTX $XENE $BHVN Full video:"
X Link @BiotechTV 2025-10-08T22:28Z 9437 followers, 37.9K engagements

": BiotechTV will be back in NYC broadcasting from the iconic @NYSE tomorrow afternoon. Please tune in. $NUVB $IMRX"
X Link @BiotechTV 2025-10-07T19:20Z 9437 followers, 12.1K engagements

": Souffl Therapeutics exited stealth today with the goal of developing nucleic acid therapies like siRNAs & ASOs delivered to any cell in the body by targeting internalizing receptors. CEO @VCAmir talks the science. Full video:"
X Link @BiotechTV 2025-10-07T13:01Z 9432 followers, 4183 engagements

": @AstriaTx licensed its HAE treatment Navenibart to Kaken Pharmaceutical for the Japanese market. It is a kallikrein inhibitor that is in phase X and is dosed up to every six months. $ATXS Full video:"
X Link @BiotechTV 2025-08-07T19:25Z 9438 followers, 1830 engagements

": Sunrise Group which has designed a mandibular sensor for at-home diagnosis of sleep apnea recently raised $29M to expand its digital sleep clinic that patients can access remotely. Full video:"
X Link @BiotechTV 2025-10-10T21:03Z 9438 followers, 1166 engagements

": @Dyne_tx's CSO Ron Batra describes the company's FORCE platform and previews big trial readouts scheduled in DMD and DM1 over the next year. $DYN Full video:"
X Link @BiotechTV 2025-10-14T16:18Z 9437 followers, 1327 engagements

": @LegendBiotech's CEO Ying Huang discusses new CARVYKTI data at #ASCO25 as well as early stage data for emerging CAR-T targets against solid tumors. $LEGN Full video:"
X Link @BiotechTV 2025-06-02T00:23Z 9429 followers, 6118 engagements

": IDEAYA Biosciences is at the forefront of precision oncology - we discuss the pipeline including a key pivotal trial that will read out for Darovasertib by the end of the year. $IDYA Full video:"
X Link @BiotechTV 2025-08-12T19:52Z 9433 followers, 22K engagements

": Kate Haviland discusses the $9B+ acquisition of Blueprint by Sanofi being chair of Fulcrum her thoughts on M&A and what is interesting in biotech today. Full video:"
X Link @BiotechTV 2025-10-14T23:33Z 9438 followers, 1633 engagements